Skip to main content
. 2019 May 31;10:905. doi: 10.3389/fimmu.2019.00905

Figure 1.

Figure 1

Distribution of CSF NLRP3 inflammasomes and cytokines levels in anti-NMDAR encephalitis patients and controls groups [viral meningoencephalitis (VM) and non-inflammatory neurological diseases (Controls)]. Higher levels of CSF NLRP3 inflammasomes were found in anti-NMDAR encephalitis and VM patients (A). CSF IL-1β levels of anti-NMDAR encephalitis patients had significant difference with controls (B). CSF levels of IL-6 showed elevated in patients with anti-NMDAR encephalitis (C). The levels of IL-17 were also significantly changed in anti-NMDAR encephalitis and VM patients (D). The correlation between mRS score and CSF NLRP3 inflammasomes in anti-NMDAR encephalitis patients in acute stage (E). The correlation between the δmRS and the decrease of CSF NLRP3 inflammasomes in patients with anti-NMDAR encephalitis in follow-up period (F). The p-values and r values were indicated within figures. (mRS, modified Rankin Scale; VM, viral meningoencephalitis).